SI-Bone closes 8.2M common stock IPO, company CEO rings NASDAQ opening bell — 4 insights

Written by Jackie Drees | December 03, 2018 | Print  |

Minimally invasive surgical device company SI-Bone closed its initial public offering of 8.28 million shares of common stock in October.

Here are four insights:

1. The more than 8 million shares of common stock were priced at $15 per share to the public.

2. All offered by SI-Bone, the shares began trading on the NASDAQ global market Oct. 17.

3. In celebration of the shares going public, SI-Bone CEO and President Jeffrey Dunn rang the opening bell at the New York City-based NASDAQ MarketSite in Times Square Nov. 30.

4. SI-Bone created the iFuse Implant System, which is a minimally invasive surgical system designed to fuse the sacroiliac joint to treat sacroiliac joint dysfunction.

More articles on devices and implants:
Medtronic CEO Omar Ishrak visits Israel among recent, potential new acquisitions: 5 things to know
Exparel launches patient education website with non-opioid pain management information, resources
Former Zimmer Biomet SVP loses bid for severance in court: 5 insights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers